Daanish Chawala, MBA

Daanish Chawala practices at Good Samaritan Hospital in Suffern, New York, part of Westchester Medical Center Health Network.

Daanish Chawala's NPI, 1104388792, was assigned on April 2, 2019. Daanish Chawala holds New York license 317044.

Daanish Chawala's primary practice is Good Samaritan Hospital, at 255 Lafayette Avenue, Suffern, NY 10901 in Rockland County. The practice phone is (914) 368-5000.

Daanish Chawala's primary practice is Good Samaritan Hospital in Suffern, New York, part of Westchester Medical Center Health Network. Daanish Chawala is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Daanish Chawala to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daanish Chawala practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Daanish Chawala's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Daanish Chawala is licensed in New York.

CMS data shows 1,440 Medicare services from Daanish Chawala across 5 procedure codes in 2024, for 523 Medicare patients. Medicare paid $140,802 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 523 Medicare patients who saw Daanish Chawala in 2024. The largest group is 75 to 84, with 194 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daanish Chawala's median patient age at 79, with 54% women.

In 2024, Daanish Chawala wrote 411 Medicare Part D claims for 191 patients. 87% of them were for generic drugs. CMS names the drug for 156 of them, across 9 drugs with 11 or more claims each, at $9,665 in total drug cost. In 2023, CMS named 147 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Daanish Chawala for performance year 2024, reported as part of a group. Daanish Chawala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Daanish Chawala in 2017. Daanish Chawala's most frequent co-author is Akhilesh Keshav Sista, MD.

CMS Open Payments shows 1 general payment to Daanish Chawala from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $150.